Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway
Archives of Biochemistry and Biophysics · 2025
DOI: 10.1016/j.abb.2025.110316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Mengying Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electron…. Hauptthemen laut MEDLINE: Ferroptosis, Atherosclerosis, Nanoparticles, Macrophages. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Zhongnan Hospital of Wuhan University, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
BACKGROUND: Astaxanthin (ASX), a fat-soluble carotenoid mainly sourced from Haematococcus pluvialis, shows promise for clinical applications in chronic inflammatory diseases. This study investigates whether ASX can mitigate atherosclerosis (AS) by modulating macrophage ferroptosis and provides astaxanthin-loaded polylactic acid-glycolic acid nanoparticles (ASX-PLGA NPs) as comparison. METHOD: ApoE-/- mice were fed a high-fat diet with ASX or statin intervention. Plaque area, lipid aggregation, collagen content, and ferroptosis-related indicators were assessed. Moreover, ASX-PLGA NPs were synthesized and characterized and were used to pretreat macrophages induced with oxidized low-density lipoprotein (ox-LDL). Indicators linked to ferroptosis and oxidative stress were detected. Finally, the expression of nuclear factor erythroid -related factor 2 (NRF2) was evaluated. RESULTS: ASX intervention significantly delayed the progression of AS plaques, characterized by reductions in plaque area and increased collagen fibers. The observed improvements in AS were consistent with statins. ASX-PLGA NPs demonstrate good safety and stability and have better therapeutic effects than ASX alone. Indicators linked to ferroptosis and oxidative stress were significantly improved in groups containing ASX in vivo and vitro. Additionally, ASX facilitated the nuclear translocation of NRF2, which could be attenuated with ML385, a specific inhibitor of NRF2. CONCLUSION: ASX-PLGA NPs have better therapeutic effects than ASX alone. The regulation of NRF2/SLC7A11/GPX4 represents a novel mechanism by which ASX can counteract ferroptosis and impede AS progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 2017302180262@whu.edu.cn.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 2019305232008@whu.edu.cn.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 865546617@qq.com.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: pengyy@whu.edu.cn.
- Department of Cardiology, Hainan General Hospital and Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, China. Electronic address: linliavia@outlook.com.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 303516390@qq.com.
Förderung
- China Scholarship Council
- Zhongnan Hospital of Wuhan University
- Natural Science Foundation of Hubei Province
Zitieren
APA
Jin, M., Chen, X., Zheng, L., Peng, Y., Lin, M., Liang, K., Liu, X., Xu, Z., Yang, Y., Wei, B., & Wan, J. (2025). Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110316
Vancouver
Jin M, Chen X, Zheng L, Peng Y, Lin M, Liang K, et al. Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110316
BibTeX
@article{Jin2025,
author = {Jin, Mengying and Chen, Xiao and Zheng, Lanzhuoying and Peng, Yuanyuan and Lin, Mingying and Liang, Ke and Liu, Xinran and Xu, Zihan and Yang, Yiming and Wei, Baozhu and Wan, Jing},
title = {Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway},
journal = {Archives of Biochemistry and Biophysics},
year = {2025},
doi = {10.1016/j.abb.2025.110316}
}
EUVIMED